ASX News Health Care Argenica doses final patients in acute ischaemic stroke trial Argenica Therapeutics Ltd has taken an important step in completion of its Phase 2 trial to… Caroline Smith1 min11 April 2025 09:53 (AEDT)
ASX News Health Care Study finds Nyrada’s lead drug can prevent secondary brain injury Nyrada Inc has reported strong results from a collaborative study it has been engaged in regarding… Caroline Smith2 mins07 April 2025 10:24 (AEDT)
ASX News Health Care Neurizon finds positive results for lead drug in 3D brain model study Neurizon Therapeutics Ltd has completed a study together with Tessara Therapeutics on the impact of NUZ-001… Caroline Smith2 mins01 April 2025 11:53 (AEDT)
ASX News Health Care Nyrada doses first cohort in trial to assess neuroprotective, cardioprotective drug Nyrada Inc has dosed the first cohort of patients in its Phase I first-in-human trial to… Caroline Smith2 mins31 March 2025 11:30 (AEDT)
ASX News Health Care FDA awards Argenica two key designations for drug candidate targeting infant brain injury Argenica Therapeutics Ltd has received two key designations from the US Food and Drug Administration for… Caroline Smith2 mins30 October 2024 14:45 (AEDT)
ASX News Health Care Nyrada rat study shows no genotoxicity in brain injury drug NYR-BI03 Nyrada Inc has completed an in-vivo micronucleus on the effects of its NYR-BI03 drug on rats,… Caroline Smith1 min07 October 2024 10:16 (AEDT)